SWOT Analysis for Rocket Pharmaceuticals Inc

Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding
Stocks with Quarter Change % less than Industry
PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter